Form 4 Filing for IN8BIO, INC.

Kate Rochlin, Chief Operating Officer of IN8BIO, INC., reported a transaction on December 22, 2025. She acquired 7,247 shares of Common Stock at a price of $1.38 per share. This transaction was made after a 1-for-30 reverse stock split, which adjusted the reported securities. Following this acquisition, Rochlin directly owns 9,085 shares of the company's common stock. The filing was signed by William Ho as Attorney-in-Fact on December 23, 2025. This transaction is classified as an acquisition of securities by an officer.